Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods.
about
Assessment of Fidelity in Interventions to Improve Hand Hygiene of Healthcare Workers: A Systematic ReviewWhole Genome Sequencing-Implications for Infection Prevention and Outbreak Investigations.Costs associated with health care-associated infections in cardiac surgeryAssessing the sustainability of daily chlorhexidine bathing in the intensive care unit of a Veteran's Hospital by examining nurses' perspectives and experiences.How externalities impact an evaluation of strategies to prevent antimicrobial resistance in health care organizationsAssociation between preoperative 25-hydroxyvitamin D level and hospital-acquired infections following Roux-en-Y gastric bypass surgeryNosocomial infections in Tbilisi, Georgia: a retrospective study of microbiological data from 4 major tertiary care hospitals.Antibacterial resistance in sub-Saharan Africa: an underestimated emergency.Hospital costs of nosocomial multi-drug resistant Pseudomonas aeruginosa acquisition.Nosocomial infection in adult admissions with hematological malignancies originating from different lineages: a prospective observational study.Incidence of hospital-acquired pneumonia, bacteraemia and urinary tract infections in patients with haematological malignancies, 2004-2010: a surveillance-based studyAttributable cost and length of stay for central line-associated bloodstream infections.Potent bactericidal efficacy of copper oxide impregnated non-porous solid surfaces.Chlorhexidine bathing and health care-associated infections: a randomized clinical trial.Cost Attributable to Nosocomial Bacteremia. Analysis According to Microorganism and Antimicrobial Sensitivity in a University Hospital in Barcelona.Vitamin D's potential to reduce the risk of hospital-acquired infections.Costs of healthcare- and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms.Association between prehospital vitamin D status and hospital-acquired bloodstream infectionsPrevention of nosocomial infections in critically ill patients with lactoferrin (PREVAIL study): study protocol for a randomized controlled trialIncidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals.Chlorhexidine bathing and health care-associated infections among adult intensive care patients: a systematic review and meta-analysis.How does work disability of patients with MS develop before and after diagnosis? A nationwide cohort study with a reference group.Regression models for analyzing costs and their determinants in health care: an introductory review.Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials.The Magnitude of Time-Dependent Bias in the Estimation of Excess Length of Stay Attributable to Healthcare-Associated Infections.Antimicrobial Resistance in the Intensive Care Unit: A Focus on Gram-Negative Bacterial Infections.The efficacy of daily chlorhexidine bathing for preventing healthcare-associated infections in adult intensive care units.Impact on morbidity, mortality and length of stay of hospital acquired infections by resistant microorganisms.Cost-effectiveness analysis of universal screening for carbapenemase-producing Enterobacteriaceae in hospital inpatients.Hand Hygiene Compliance in the Setting of Trauma Resuscitation.The Value of E-Learning for the Prevention of Healthcare-Associated Infections.Understanding chlorhexidine decolonization strategies.Another look at CHG bathing in a surgical intensive care unitEvery other day bathing with chlorhexidine gluconate: what is the evidence?Optimizing delivery of care for patients with MRSA infection: focus on transitions of care.Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study.Effect of daily chlorhexidine bathing on hospital-acquired infection.Financial Incentives to Reduce Hospital-Acquired Infections Under Alternative Payment Arrangements.Cost of hospitalised patients due to complicated urinary tract infections: a retrospective observational study in countries with high prevalence of multidrug-resistant Gram-negative bacteria: the COMBACTE-MAGNET, RESCUING study.
P2860
Q27302140-DA8715BC-F5EB-436D-85C0-C37C9109868EQ30235348-F4FD469F-9983-4741-B7E7-BEE5CE767F35Q30300984-706A864B-12C1-42F6-9A1A-6171D098EE0BQ30835034-F9333687-424C-49C4-90B9-9695FCF23CA3Q33759333-B66D78FE-380C-45FA-BBE3-F26AB3EA387BQ33775588-932CE5A0-D2A4-4F2E-AA50-6271E2F7B994Q33987273-5A68DACA-0FC9-4C2B-B1DA-8A284A6DBCA2Q34156590-A0F6BC27-F566-4504-9F38-AC09F6636867Q34279206-CCE39BE3-3B59-4DF0-A41A-0DE1360E76D3Q34557550-641AA2FB-2A5F-459B-BA9A-28AE72E73FD0Q34614712-84541989-2AFE-4122-BC85-64748BDD4B54Q34648136-381BE24A-4173-4C61-A9F0-1C5A1BC6A0BAQ35113954-E3FE4D3B-347F-4492-B494-89DBC254B7F2Q35247984-48B7D7AF-00AC-4B87-BC28-4B7FBC215A00Q35982731-A867CAFF-C128-4BF9-95D0-766A8CC51549Q36187615-3480069D-D575-41F1-8B05-B5112EAB2AF7Q36379588-2C097D3F-3575-42D9-B2A8-BA490BBB05DCQ37187256-27AE4CF0-E180-4466-95DE-BAB7BC85BDB6Q37295042-BD35B9CA-88C9-478B-82BC-477C43D3C731Q37426944-98CF3B4B-0565-48AA-BBBD-4C21CAA7DFC3Q37431630-7960EF8F-BDC0-4B76-8152-80ACC0F4B5A3Q37454602-D666D289-67A7-4CEC-9639-7F33B3AE3C21Q37866920-7AA6FB33-A6E8-48C0-9EE5-978EB5D554ABQ38286351-3DBEE7D1-8196-4C5F-B49B-7D8EC9B97659Q38515096-23C0E98A-2F8D-4A8F-BB9F-92EFD1B15BD7Q38697988-1AEE21B7-9884-4DE1-9075-B96FEA0E6077Q38798917-865F4078-F00A-48AD-98D0-B80C15C99B1BQ40226218-66B456A0-3299-4327-AEE5-09A8588B1AE0Q40375426-E0EB73ED-0AE0-431F-B1D4-BF1EDBBD1705Q40560627-B734B760-595C-4761-8912-028B6041E17AQ40676403-43349DF3-BDBF-4F77-81A5-81800BFAED12Q41151944-CD78BC13-4FFE-436A-8FE5-EA2DFC4C969CQ42328771-EF54D008-9E38-443A-9C53-965CDE9A980FQ42330849-43672EDE-2B0D-442D-9035-E1B61FF5EDF0Q45183500-D473765F-5C56-49E1-B513-DDCD39D85F9FQ45958105-CCB5D3E8-72D7-488D-B9EA-3301BBB29747Q47128177-8574A48A-3AA8-4579-BB4E-779C5D9766CFQ49852911-0C134F66-35A3-493A-9B6D-2211B589803EQ53830349-B47B2AE0-934C-4C46-A36B-7C11B39E35E7
P2860
Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Costs attributable to healthca ...... omparison of economic methods.
@en
Costs attributable to healthca ...... omparison of economic methods.
@nl
type
label
Costs attributable to healthca ...... omparison of economic methods.
@en
Costs attributable to healthca ...... omparison of economic methods.
@nl
prefLabel
Costs attributable to healthca ...... omparison of economic methods.
@en
Costs attributable to healthca ...... omparison of economic methods.
@nl
P2093
P1433
P1476
Costs attributable to healthca ...... omparison of economic methods.
@en
P2093
Fauzia Abbasi
Ginevra G Ciavarella
Ibrar Ahmad
Linda M Kampe
R Douglas Scott
Ralph Cordell
Rebecca R Roberts
Reidar Hagtvedt
Robert A Weinstein
P304
P356
10.1097/MLR.0B013E3181EF60A2
P577
2010-11-01T00:00:00Z